Medindia
Why Register as Premium Member if you have Diabetes? Click Here
Medindia » News on IT in Healthcare

App-based Video Exercises Support Rehabilitation for Differently-abled Individuals

by Vishnu on June 3, 2023 at 10:02 AM
Listen to this News

Apps are widely prevalent in various aspects of life, including healthcare. In the case of individuals with rhythmic movement disorder (RMD), personalized video exercises (PEV) can be beneficial for supporting rehabilitation and physical exercise.


In an abstract shared at the 2023 EULAR annual congress, Davergne and colleagues explore the effectiveness of PEV provided through Apps in supporting rehabilitation for differently-abled people. The impact was measured in terms of a range of outcomes, including the effect on functional capacity, confidence in exercise performance, use of care, health-related quality of life, adherence, and adverse events.

‘The analysis encompassed 7 articles with data from 906 participants, the majority (93%) being adults. The Apps utilized in these studies were predominantly commercial, with 80% of the videos featuring physiotherapist-created content. App usage duration varied from 3 to 48 weeks. #Disability # Physiotherapy’

Data were collected in a systematic review of randomized controlled trials which evaluated the effect of Apps providing PEV to support physical rehabilitation for any RMD. The primary outcome was functional capacity at the end of the intervention.

Apps Offering PEV Show Significant Improvement in Physical Function

In total, 7 articles were included, representing data from 906 participants, 93% of whom were adults. The Apps used in these studies were mostly commercial, and 80% of the videos included content from a physiotherapist. The duration of App use ranged from 3 to 48 weeks.

Low-quality evidence suggested the use of Apps providing PEV led to a significant, but small-to-moderate improvement in physical function, confidence in exercise performance, quality of life, and adherence. However, use of Apps providing PEV did not influence rate of adverse events experienced by people taking part in the trials.

Whilst these results are interesting, the authors note that the level of evidence was low. More robust studies are needed to confirm these findings in people with RMD, and to work out which features of Apps and PEV have the greatest impact.


Source: Eurekalert

View Non AMP Site | Back to top ↑